The Financial Times & McKinsey Business Book of the Year A New York Times Notable Book A
Washington Post Notable Book One of the Best Books of the Year: NPR San Francisco Chronicle
Time Esquire Fortune Marie Claire GQ Mental Floss Science Friday Bloomberg Popular
Mechanics BookRiot The Seattle Times The Oregonian Publishers Weekly Library Journal In
2014 Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a
brilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry
with its breakthrough device which performed the whole range of laboratory tests from a single
drop of blood. Backed by investors such as Larry Ellison and Tim Draper Theranos sold shares
in a fundraising round that valued the company at more than $9 billion putting Holmes's worth
at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous
results put patients in danger leading to misdiagnoses and unnecessary treatments. All the
while Holmes and her partner Sunny Balwani worked to silence anyone who voiced
misgivings-from journalists to their own employees. Rigorously reported and fearlessly written
Bad Blood is a gripping story of the biggest corporate fraud since Enron-a tale of ambition and
hubris set amid the bold promises of Silicon Valley.
